Indepth interview available now on www.cantos.com with Georges Jacobs, Chairman of the Executive Committee, UCB
* Strategy and fit
* Why Celltech?
* Financing and integration
and Dr Roch Doliveux, CEO, UCB Pharma
* CDP 870
* Why Celltech?
* Biotech v. pharma
* Competing in the US
* Integration
A video interview is also available with Dr Goran Ando, CEO, Celltech.
An on-demand webcast of the investor presentation will be available later today.
Press Release Actions
Recommended Reading
-
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the ordinary general meeting of the shareholders (the “General Meeting”) which will be held...
Read More